Member access

4-Traders Homepage  >  News

News

Latest NewsCompaniesMarketsEconomy & ForexCommoditiesHot NewsMost Read NewsRecomm.Business LeadersVideosCalendar 

Johnson & Johnson Innovation Announces Collaborations with Two Canadian Early-Stage Drug Technology Development Centers

12/10/2013 | 08:09am US/Eastern

Johnson & Johnson Innovation and its affiliate Janssen Inc. in Canada today announced new collaborations with two Canadian early-stage drug technology development centers, Montreal-based NEOMED and Toronto-based MaRS Innovation, to identify and advance promising bio/pharmaceutical technologies that have the potential to impact human health.

Through these collaborations, technical experts from the Johnson & Johnson Innovation Center in Boston, Massachusetts will work with NEOMED and MaRS Innovation to identify investment opportunities emerging from well-validated scientific research discoveries within their communities of academic institutions and biotechnology companies.

"We know from our history of engagement that the Canadian bio/pharmaceutical environment is one of the most vibrant in the world," said Robert Urban, Head of the Johnson & Johnson Innovation Center, Boston. "These new collaborations will allow us to potentially advance important new clinical candidates against disease."

"Quebec and Ontario are home to numerous world-class academic and biomedical research enterprises," said Paul Kershaw, Vice President of Medical Affairs, Janssen Inc. in Canada. "These new relationships with NEOMED and MaRS Innovation are an extension of our commitment to Canada's innovative research community."

NEOMED is a not-for-profit, public-private Pharma alliance dedicated to drug discovery and development. Partially funded by the Ministère des Finances et de l'Économie du Québec, NEOMED is within the NEOMED Institute, a state-of-the-art R&D facility in the Montréal Technoparc.

MaRS Innovation is the commercialization agent for Ontario's discovery pipeline from 16 leading academic institutions. MaRS Innovation is supported by the Government of Canada through the Networks of Centres of Excellence, by the Government of Ontario through the Ontario Centres of Excellence, and by its 16 member institutions.

About Johnson & Johnson Innovation

The Boston Innovation Center is part of Johnson & Johnson Innovation, a division of Johnson & Johnson Finance Corporation. Johnson & Johnson Innovation focuses on accelerating early innovation and enhancing opportunities for collaboration and investment across Johnson & Johnson's global healthcare businesses. Johnson & Johnson Innovation provides scientists, entrepreneurs and emerging companies focused on early-stage opportunities a one-stop access to science and technology experts who can facilitate collaborations across the pharmaceutical, medical device and diagnostics and consumer companies of Johnson & Johnson. Johnson & Johnson Innovation includes local deal-making capabilities with the flexibility to adapt deal structures to match early-stage opportunities and establish novel collaborations that speed development of those innovations to solve unmet needs in patients. Follow us @jnjinnovation on Twitter. Please visit www.jnjinnovation.com for more information.

About Janssen Inc.

Janssen is dedicated to addressing and solving some of the most important unmet medical needs of our time in oncology, immunology, neuroscience, infectious diseases and vaccines, metabolic and chronic diseases and women's health. Driven by our commitment to patients, we bring innovative products, services and solutions to people throughout the world. Janssen Inc. in Canada is part of the Janssen Pharmaceutical Companies of Johnson & Johnson. Please visit http://www.janssen.ca for more information.

Johnson & Johnson
John Lacey, 781-392-5514
jlacey1@ITS.JNJ.com
or
Feinstein Kean Healthcare
Jessica Rowlands, 202-729-4089
jessica.rowlands@fkhealth.com


© Business Wire 2013
Latest news
Date Title
<1m ago IXONOS : starts co-operational negotiations with its personnel in Finland 21 October 2014
<1m ago SPACEANDPEOPLE : Directorate Change
<1m ago MINISTRY OF FINANCE OF REPUBLIC OF INDIA : Project Report on “DRISHTI” Submitted to Finance Minister
<1m ago QUINDELL : Major Insurer 5 Year Contract Win
1m agoDJEurozone Budget Deficits Fall Post Tweak
1m ago BROOKS MACDONALD : *numis cuts brooks macdonald price target to 1470 pence - 'hold'
1m agoDJEuropean Stock Markets Edge Higher
1m agoDJChinese Data Drives Oil Higher
1m ago RESEARCH AND MARKETS : Denmark Power Market Outlook to 2030 - Market Trends, Regulations and Competitive Landscape Featuring Dong Energy & Vattenfall AB
2m agoDJTALKTALK TELECOM : Ofcom Rules Against TalkTalk Over BT Broadband Price Complaint
Latest news
Advertisement
Hot News 
DOMINION MIDSTREAM PARTNERS : Closes Initial Public Offering
STRATMIN GLOBAL RESOURCES : Seals Offtake Agreement With Independent Global Graphite Merchant
NCR : Third Quarter 2014 Earnings Conference Call Rescheduled for October 23
NORTHERN PETROLEUM : Drilling and production update
Blur Group Signs Tesco and Argos to Platform
Most Read News
2h ago Total CEO de Margerie killed in Moscow as jet hits snow plough
1d ago Chipotle stock dips as sales growth forecasts come down
1d ago GULFMARK OFFSHORE : Announces Third Quarter 2014 Operating Results
1d agoDJASIAN SHARES : Hang Seng Rises on China Growth Data -- Update
1d ago New Microsoft CEO pay tops $80 million with big stock awards
Most recommended articles
<1m agoDJEurozone Budget Deficits Fall Post Tweak
1m agoDJEuropean Stock Markets Edge Higher
1m agoDJChinese Data Drives Oil Higher
2m agoDJTALKTALK TELECOM : Ofcom Rules Against TalkTalk Over BT Broadband Price Complaint
3m agoDJHDFC Bank July-September Net Profit Up 20%
Dynamic quotes  
ON
| OFF